×
About 2,350 results

Zamicet - hydrocodone bitartrate and acetaminophen solution-Pharmaceutical Associates, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c84877aa-5b61-4603-9494-fcf95d22a1f1

Jul 19th, 2016 - Zamicet® (hydrocodone bitartrate and acetaminophen oral solution) is indicated for the relief of moderate to moderately severe pain.

Methylphenidate hydrochloride - methylphenidate hydrochloride capsule, extended release-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01496acd-6e62-42aa-9047-521d333e1ece

Jul 10th, 2017 - Methylphenidate hydrochloride extended-release capsules (LA) are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The efficacy of methylphenidate hydrochloride extended-release capsules (LA) in the treatment of ADHD was established in 1 controlled trial of children aged 6 to 12 who met DSM-IV criteria for ADHD (see CLINICAL PHARMACOLOGY). A diagnosis of Attention ...

Dexmethylphenidate hydrochloride - dexmethylphenidate hydrochloride capsule, extended release-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=694ebbf3-966b-4c0d-8d3c-ed95ee0dc8cb

Jul 13th, 2017 - Dexmethylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. The effectiveness of dexmethylphenidate hydrochloride extended-release in the treatment of ADHD in patients aged 6 years and older was established in 2 placebo-controlled studies in patients meeting DSM-IV criteria for ...

Lazanda - fentanyl citrate spray-Depomed, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9dcaff31-1653-11e3-8ffd-0800200c9a66

Dec 26th, 2017 - LAZANDA is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain. Patients considered opioid tolerant are those who are taking, for one week or longer, around-the-clock medicine consisting of at least: 60 mg of oral morphine per d...

Methadone hydrochloride - methadone hydrochloride tablet-CorePharma, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2373917-5c7d-4199-be4e-3cf79690a631

May 2nd, 2016 - Methadone hydrochloride tablets, USP are indicated for the: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with long-act...

Oxycodone and acetaminophen - oxycodone and acetaminophen solution-Mallinckrodt, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1affabf4-d808-4dc4-ad48-ea4fc9b3c28d

Feb 12th, 2017 - Oxycodone hydrochloride and acetaminophen oral solution is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see WARNINGS ), reserve oxycodone hydrochloride and acetaminophen oral solution for use i...

Hydrocodone bitartrate and acetaminophen - hydrocodone bitartrate and acetaminophen tablet-H.J. Harkins Company, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b4e2c4e-4e53-7794-e053-2a91aa0ab4e6

Oct 10th, 2017 - Hydrocodone bitartrate and acetaminophen tablets, USP are indicated for the relief of moderate to moderately severe pain.

Methylphenidate hydrochloride - methylphenidate hydrochloride tablet-Nostrum Laboratories, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2a8743d-7bab-442f-8a9e-5e68f61937e4

Jan 31st, 2017 - Attention Deficit Disorders (previously known as Minimal Brain Dysfunction in Children). Other terms being used to describe the behavioral syndrome below include: Hyperkinetic Child Syndrome, Minimal Brain Damage, Minimal Cerebral Dysfunction, Minor Cerebral Dysfunction. Methylphenidate Hydrochloride Tablets are indicated as an integral part of a total treatment program which typically includes...

Fentanyl - fentanyl patch-St. Marys Medical Park Pharmacy
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e190303-00f3-4a23-bed0-39fea1d15ae0

Feb 21st, 2018 - INDICATIONS AND USAGE Fentanyl transdermal system is indicated for management of persistent, moderate to severe chronic pain that: - requires continuous, around-the-clock opioid administration for an extended period of time, and - cannot be managed by other means such as non-steroidal analgesics, opioid combination products, or immediate-release opioids Fentanyl transdermal system should ONLY b...

Fentanyl - fentanyl patch-Mayne Pharma
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a10a128f-abdd-489b-8794-8b36a634a5e5

Oct 3rd, 2017 - Fentanyl transdermal system is indicated for the management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Patients considered opioid-tolerant are those who are taking, for one week or longer, at least 60 mg morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg ...

Dextroamphetamine sulfate - dextroamphetamine sulfate tablet-Novel Laboratories, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f0426b4-ecf2-4345-b1cf-c5f48832126b

Dec 21st, 2017 - Dextroamphetamine Sulfate Tablets USP are indicated for: 1. Narcolepsy. 2.         Attention Deficit Disorder with Hyperactivity, as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 to 16 years) with a behavioral syndrome characterized by the following group ...

Oxycodone and acetaminophen - oxycodone and acetaminophen tablet-Aidarex Pharmaceuticals LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18272310-e63b-4a5c-80b6-2a69abc7658b

Nov 29th, 2016 - Oxycodone and Acetaminophen Tablets is indicated for the relief of moderate to moderately severe pain.

Oxycodone and acetaminophen - oxycodone and acetaminophen tablet-Lake Erie Medical DBA Quality Care products LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f2b939c-2206-469b-85a4-b0ee9ba25be8

Jan 2nd, 2017 - INDICATIONS AND USAGE Oxycodone and acetaminophen tablets USP are indicated for the relief of moderate to moderately severe pain.

Hydrocodone bitartrate and acetaminophen - hydrocodone bitartrate and acetaminophen tablet-Allergan, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7c2f876c-345c-4417-986d-804d10a923a3

Dec 21st, 2016 - Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS ], reserve Hydrocodone Bitartrate and Acetaminophen Tablets for use in patients fo...

Metadate cd - methylphenidate hydrochloride capsule, extended release-Unither Manufacturing, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6aedc40-5725-4bd3-9037-033746e8599e

Oct 10th, 2016 - METADATE CD (methylphenidate HCl, USP) Extended-Release Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The efficacy of METADATE CD in the treatment of ADHD was established in one controlled trial of children aged 6 to 15 who met DSM-IV criteria for ADHD (see CLINICAL PHARMACOLOGY). A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-I...

Norco - hydrocodone bitartate and acetaminophen tablet-Allergan, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d47117b0-f943-4fd1-8775-2aa2f77d61b4

Dec 21st, 2016 - Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS ], reserve Hydrocodone Bitartrate and Acetaminophen Tablets for use in patients fo...

Hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride oral solution - hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride solution-Tris...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a29a740d-ee23-459b-804a-891022702bc3

Oct 14th, 2014 - Hydrocodone bitartrate, chlorpheniramine maleate, and pseudoephedrine hydrochloride oral solution is a combination product containing an antitussive, an antihistamine, and a nasal decongestant indicated for: Relief of cough and nasal congestion associated with common cold. (1.1) Relief of symptoms including nasal congestion associated with upper respiratory allergies. (1.2) Important Limitation...

Hydrocodone bitartrate and pseudoephedrine hydrochloride solution - hydrocodone bitartrate and pseudoephedrine hydrochloride solution-Tris Pharma Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d8344453-c7c0-4e4b-aab7-8447ef28322a

Oct 14th, 2014 - Hydrocodone bitartrate and pseudoephedrine hydrochloride oral solution is a combination product containing an antitussive and nasal decongestant indicated for: Relief of cough and nasal congestion associated with common cold. Important Limitations of Use: Not indicated for pediatric patients under 18 years of age Hydrocodone bitartrate and pseudoephedrine hydrochloride oral solution is indicate...

Morphine sulfate - morphine sulfate tablet, film coated, extended release-CorePharma, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46dd9d3e-453a-4211-8aed-7dfedb015ba8

Mar 30th, 2017 - Morphine sulfate extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with exte...

Dilaudid - hydromorphone hydrochloride injection, solution-Fresenius Kabi USA, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d77772f-874f-9c87-2d80-ca467c7690a1

Jan 18th, 2018 - DILAUDID INJECTION is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions (5.1)], reserve DILAUDID INJECTION for use in patients for whom alternative treatment options [e.g....